These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 37014501)

  • 1. The Hong Kong Society of Rheumatology consensus recommendations for the management of gout.
    Yip RM; Cheung TT; So H; Chan JP; Ho CT; Tsang HH; Yu CK; Wong PC;
    Clin Rheumatol; 2023 Aug; 42(8):2013-2027. PubMed ID: 37014501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of gout and hyperuricemia: Multidisciplinary consensus in Taiwan.
    Yu KH; Chen DY; Chen JH; Chen SY; Chen SM; Cheng TT; Hsieh SC; Hsieh TY; Hsu PF; Kuo CF; Kuo MC; Lam HC; Lee IT; Liang TH; Lin HY; Lin SC; Tsai WP; Tsay GJ; Wei JC; Yang CH; Tsai WC
    Int J Rheum Dis; 2018 Apr; 21(4):772-787. PubMed ID: 29363262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of gout in Hong Kong: a population-based study from 2006 to 2016.
    Tsoi MF; Chung MH; Cheung BMY; Lau CS; Cheung TT
    Arthritis Res Ther; 2020 Sep; 22(1):204. PubMed ID: 32887668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gout and cardiovascular risk].
    Němec P
    Vnitr Lek; 2014 Oct; 60(10):893-901. PubMed ID: 25382012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2020 recommendations from the French Society of Rheumatology for the management of gout: Urate-lowering therapy.
    Pascart T; Latourte A; Flipo RM; Chalès G; Coblentz-Baumann L; Cohen-Solal A; Ea HK; Grichy J; Letavernier E; Lioté F; Ottaviani S; Sigwalt P; Vandecandelaere G; Richette P; Bardin T
    Joint Bone Spine; 2020 Oct; 87(5):395-404. PubMed ID: 32422338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Questionnaire survey evaluating disease-related knowledge for 149 primary gout patients and 184 doctors in South China.
    Li QH; Dai L; Li ZX; Liu HJ; Zou CJ; Ou-Yang X; Lu M; Li T; Li YH; Mo YQ; Schumacher HR
    Clin Rheumatol; 2013 Nov; 32(11):1633-40. PubMed ID: 23857664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limitations of the Current Standards of Care for Treating Gout and Crystal Deposition in the Primary Care Setting: A Review.
    Keenan RT
    Clin Ther; 2017 Feb; 39(2):430-441. PubMed ID: 28089200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discordant American College of Physicians and international rheumatology guidelines for gout management: consensus statement of the Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN).
    Dalbeth N; Bardin T; Doherty M; Lioté F; Richette P; Saag KG; So AK; Stamp LK; Choi HK; Terkeltaub R
    Nat Rev Rheumatol; 2017 Sep; 13(9):561-568. PubMed ID: 28794514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of gout by UK rheumatologists: a British Society for Rheumatology national audit.
    Roddy E; Packham J; Obrenovic K; Rivett A; Ledingham JM
    Rheumatology (Oxford); 2018 May; 57(5):826-830. PubMed ID: 29447370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2021 Asia-Pacific League of Associations for Rheumatology clinical practice guideline for treatment of gout.
    Lorenzo JPP; Sollano MHMZ; Salido EO; Li-Yu J; Tankeh-Torres SA; Wulansari Manuaba IAR; Rahman MM; Paul BJ; Mok MY; De Silva M; Padhan P; Lim AL; Marcial M; Vicera JJ; Haq SA; Salman S; Liyanage CK; Keen HI; Yew Kuang C; Wei JC; Hellmi RY; Chan CE; Louthrenoo W
    Int J Rheum Dis; 2022 Jan; 25(1):7-20. PubMed ID: 34931463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and treatment for hyperuricemia and gout: a systematic review of clinical practice guidelines and consensus statements.
    Li Q; Li X; Wang J; Liu H; Kwong JS; Chen H; Li L; Chung SC; Shah A; Chen Y; An Z; Sun X; Hemingway H; Tian H; Li S
    BMJ Open; 2019 Aug; 9(8):e026677. PubMed ID: 31446403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gout].
    Tausche AK
    Internist (Berl); 2021 May; 62(5):513-525. PubMed ID: 33721041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperuricaemia and gout.
    Shipley M
    J R Coll Physicians Edinb; 2011 Sep; 41(3):229-33. PubMed ID: 21949921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evidence-based recommendations for diagnostics and treatment of gouty arthritis in the specialist sector : S2e guidelines of the German Society of Rheumatology in cooperation with the AWMF].
    Kiltz U; Alten R; Fleck M; Krüger K; Manger B; Müller-Ladner U; Nüsslein H; Reuss-Borst M; Schwarting A; Schulze-Koops H; Tausche AK; Braun J
    Z Rheumatol; 2017 Mar; 76(2):118-124. PubMed ID: 28078432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physician adherence to ACR gout treatment guidelines: perception versus practice.
    Oderda GM; Shiozawa A; Walsh M; Hess K; Brixner DI; Feehan M; Akhras K
    Postgrad Med; 2014 May; 126(3):257-67. PubMed ID: 24918810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Management of Gout in Renal Disease.
    Estiverne C; Mount DB
    Semin Nephrol; 2020 Nov; 40(6):600-613. PubMed ID: 33678314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New therapeutic approach to hyperuricemia and gout in the light of recommendations.
    Lioté F
    Joint Bone Spine; 2016 Jul; 83(4):376-80. PubMed ID: 27085801
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of gout by Moroccan rheumatologists: a Moroccan Society for Rheumatology National Survey.
    Moulay Berkchi J; Rkain H; Benbrahim L; Aktaou S; Lazrak N; Faiz S; Ahid S; Abouqal R; Labzizi S; Ouzeddoun N; Oukerraj L; Hmamouchi I; Hajjaj-Hassouni N; Allali F
    Rheumatol Int; 2020 Sep; 40(9):1399-1408. PubMed ID: 32447422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uric acid-lowering effect of dotinurad, a novel selective urate reabsorption inhibitor, in hypertensive patients with gout or asymptomatic hyperuricemia: a pooled analysis of individual participant data in phase II and III trials.
    Takahashi T; Beppu T; Hidaka Y; Hosoya T
    Clin Exp Hypertens; 2021 Nov; 43(8):730-741. PubMed ID: 34425059
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular Disease in Gout and the Protective Effect of Treatments Including Urate-Lowering Therapy.
    Gupta MK; Singh JA
    Drugs; 2019 Apr; 79(5):531-541. PubMed ID: 30868398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.